Manager TitleAgeSince
Chief Executive Officer 86 31/08/2013
Director of Finance/CFO 55 30/09/2012
Director TitleAgeSince
Chairman 54 11/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-38.68% - - 106K
-1.40%+2.59%-1.71%+11.28% 48.53B
-2.41%-0.90%+411.96%+495.33% 39.87B
-1.16%+12.96%+28.81%+7.25% 38.68B
-1.88%-3.03%+5.69%+53.00% 35.13B
-1.74%+5.12%+14.44%+41.77% 29.79B
-0.21%-4.04%+36.40%+125.75% 16.11B
-2.85%-3.92% - - 16.08B
-0.64%+2.65%+3.40%+13.11% 13.61B
-1.19%-1.32%-1.73%-34.37% 12.62B
Average -1.35%+1.05%+62.16%+89.14% 27.82B
Weighted average by Cap. -1.60%+2.03%+79.78%+108.61%

Financials

2020 2021
Net sales 1.5M 1.73M 1.4M 1.28M 2.42M 165M 2.46M 16.48M 6.47M 82.13M 6.49M 6.35M 275M 1.08M 1.24M 1M 920K 1.74M 118M 1.77M 11.82M 4.64M 58.89M 4.65M 4.55M 197M
Net income 14.75M 16.96M 13.73M 12.6M 23.8M 1.62B 24.17M 162M 63.5M 806M 63.71M 62.31M 2.7B -10.57M -12.16M -9.84M -9.04M -17.06M -1.16B -17.33M -116M -45.53M -578M -45.68M -44.68M -1.94B
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33